Therefore, similar to c-Mpl (Ng et al., 2014), a tight regulation of C3G expression in platelets and MKs could play a role in the prevention of megakaryocytosis, thrombocytosis and myeloproliferative disorders. Here, RAPGEF1 is linked to myeloproliferative disorder.